CAY10597 |
A potent CRTH2 / DP2 receptor antagonist that binds to the human receptor… |
5 mg |
10012539-5 |
More Info
|
CAY10598 |
A very potent agonist of EP4, binding with a Ki value of 1.2 nM; does not… |
1 mg |
13281-1 |
More Info
|
CAY10598 |
A very potent agonist of EP4, binding with a Ki value of 1.2 nM; does not… |
10 mg |
13281-10 |
More Info
|
CAY10598 |
A very potent agonist of EP4, binding with a Ki value of 1.2 nM; does not… |
5 mg |
13281-5 |
More Info
|
CAY10598 |
A very potent agonist of EP4, binding with a Ki value of 1.2 nM; does not… |
500 µg |
13281-500 |
More Info
|
CAY10599 |
An agonist of PPARγ (EC50 = 0.05 µM); selective for PPAR&gamma… |
1 mg |
13282-1 |
More Info
|
CAY10599 |
An agonist of PPARγ (EC50 = 0.05 µM); selective for PPAR&gamma… |
10 mg |
13282-10 |
More Info
|
CAY10599 |
An agonist of PPARγ (EC50 = 0.05 µM); selective for PPAR&gamma… |
5 mg |
13282-5 |
More Info
|
CAY10599 |
An agonist of PPARγ (EC50 = 0.05 µM); selective for PPAR&gamma… |
500 µg |
13282-500 |
More Info
|
CAY10602 |
A SIRT1 activator; inhibits LPS-induced TNF-α release in THP-1 cells… |
10 mg |
10009796-10 |
More Info
|
CAY10602 |
A SIRT1 activator; inhibits LPS-induced TNF-α release in THP-1 cells… |
100 mg |
10009796-100 |
More Info
|
CAY10602 |
A SIRT1 activator; inhibits LPS-induced TNF-α release in THP-1 cells… |
5 mg |
10009796-5 |
More Info
|
CAY10602 |
A SIRT1 activator; inhibits LPS-induced TNF-α release in THP-1 cells… |
50 mg |
10009796-50 |
More Info
|
CAY10603 |
A potent and selective inhibitor of HDAC6 (IC50 = 0.002 nM, as compared wi… |
1 mg |
13146-1 |
More Info
|
CAY10603 |
A potent and selective inhibitor of HDAC6 (IC50 = 0.002 nM, as compared wi… |
10 mg |
13146-10 |
More Info
|
CAY10603 |
A potent and selective inhibitor of HDAC6 (IC50 = 0.002 nM, as compared wi… |
25 mg |
13146-25 |
More Info
|
CAY10603 |
A potent and selective inhibitor of HDAC6 (IC50 = 0.002 nM, as compared wi… |
5 mg |
13146-5 |
More Info
|
CAY10606 |
A potent, reversible inhibitor of 5-LO, in cell-free assays (IC50 = 86 nM)… |
1 mg |
13381-1 |
More Info
|
CAY10606 |
A potent, reversible inhibitor of 5-LO, in cell-free assays (IC50 = 86 nM)… |
5 mg |
13381-5 |
More Info
|
CAY10608 |
A propanolamine that potently, selectively, and non-competitively antagoni… |
1 mg |
13358-1 |
More Info
|
CAY10608 |
A propanolamine that potently, selectively, and non-competitively antagoni… |
10 mg |
13358-10 |
More Info
|
CAY10608 |
A propanolamine that potently, selectively, and non-competitively antagoni… |
25 mg |
13358-25 |
More Info
|
CAY10608 |
A propanolamine that potently, selectively, and non-competitively antagoni… |
5 mg |
13358-5 |
More Info
|
CAY10614 |
An antagonist of lipid A activation of TLR4 (IC50 =1.68 µM), in a ce… |
1 mg |
13615-1 |
More Info
|
CAY10614 |
An antagonist of lipid A activation of TLR4 (IC50 =1.68 µM), in a ce… |
10 mg |
13615-10 |
More Info
|
CAY10614 |
An antagonist of lipid A activation of TLR4 (IC50 =1.68 µM), in a ce… |
25 mg |
13615-25 |
More Info
|
CAY10614 |
An antagonist of lipid A activation of TLR4 (IC50 =1.68 µM), in a ce… |
5 mg |
13615-5 |
More Info
|
CAY10616 |
An analog of resveratrol which potently induces apoptosis in HL-60 cells (… |
1 mg |
13291-1 |
More Info
|
CAY10616 |
An analog of resveratrol which potently induces apoptosis in HL-60 cells (… |
10 mg |
13291-10 |
More Info
|
CAY10616 |
An analog of resveratrol which potently induces apoptosis in HL-60 cells (… |
25 mg |
13291-25 |
More Info
|
CAY10616 |
An analog of resveratrol which potently induces apoptosis in HL-60 cells (… |
5 mg |
13291-5 |
More Info
|
CAY10621 |
A selective inhibitor of SPHK1 |
1 mg |
13371-1 |
More Info
|
CAY10621 |
A selective inhibitor of SPHK1 |
10 mg |
13371-10 |
More Info
|
CAY10621 |
A selective inhibitor of SPHK1 |
25 mg |
13371-25 |
More Info
|
CAY10621 |
A selective inhibitor of SPHK1 |
5 mg |
13371-5 |
More Info
|
CAY10622 |
A potent inhibitor of ROCK1 and ROCK2 (IC50s = 6 and 4 nM, respectively) |
1 mg |
13687-1 |
More Info
|
CAY10622 |
A potent inhibitor of ROCK1 and ROCK2 (IC50s = 6 and 4 nM, respectively) |
10 mg |
13687-10 |
More Info
|
CAY10622 |
A potent inhibitor of ROCK1 and ROCK2 (IC50s = 6 and 4 nM, respectively) |
5 mg |
13687-5 |
More Info
|
CAY10625 |
An antagonist of the interaction between survivin and the apoptosis-promot… |
1 mg |
13836-1 |
More Info
|
CAY10625 |
An antagonist of the interaction between survivin and the apoptosis-promot… |
10 mg |
13836-10 |
More Info
|
CAY10625 |
An antagonist of the interaction between survivin and the apoptosis-promot… |
5 mg |
13836-5 |
More Info
|
CAY10626 |
A potent, dual PI3Kα/mTOR inhibitor (IC50s = 0.9 and 0.6 nM, respect… |
1 mg |
13838-1 |
More Info
|
CAY10626 |
A potent, dual PI3Kα/mTOR inhibitor (IC50s = 0.9 and 0.6 nM, respect… |
10 mg |
13838-10 |
More Info
|
CAY10626 |
A potent, dual PI3Kα/mTOR inhibitor (IC50s = 0.9 and 0.6 nM, respect… |
25 mg |
13838-25 |
More Info
|
CAY10626 |
A potent, dual PI3Kα/mTOR inhibitor (IC50s = 0.9 and 0.6 nM, respect… |
5 mg |
13838-5 |
More Info
|
CAY10631 |
An alcohol related to a C32:6 very long chain fatty acid found in the reti… |
1 mg |
10562-1 |
More Info
|
CAY10631 |
An alcohol related to a C32:6 very long chain fatty acid found in the reti… |
10 mg |
10562-10 |
More Info
|
CAY10631 |
An alcohol related to a C32:6 very long chain fatty acid found in the reti… |
5 mg |
10562-5 |
More Info
|
CAY10631 |
An alcohol related to a C32:6 very long chain fatty acid found in the reti… |
500 µg |
10562-500 |
More Info
|
CAY10632 |
A C32:6 VLCPUFA whose specific biological actions are largely unknown, but… |
1 mg |
10497-1 |
More Info
|